Pharma-Bio Serv (PBSV) EBIAT (2016 - 2025)
Historic EBIAT for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to -$133272.0.
- Pharma-Bio Serv's EBIAT rose 1353.27% to -$133272.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$637662.0, marking a year-over-year increase of 5047.62%. This contributed to the annual value of -$637662.0 for FY2025, which is 5047.62% up from last year.
- As of Q4 2025, Pharma-Bio Serv's EBIAT stood at -$133272.0, which was up 1353.27% from -$313877.0 recorded in Q3 2025.
- In the past 5 years, Pharma-Bio Serv's EBIAT registered a high of $2.3 million during Q3 2021, and its lowest value of -$4.9 million during Q4 2021.
- For the 5-year period, Pharma-Bio Serv's EBIAT averaged around -$76468.2, with its median value being $96439.5 (2022).
- Data for Pharma-Bio Serv's EBIAT shows a peak YoY increase of 22872.01% (in 2021) and a maximum YoY decrease of 347565.8% (in 2021) over the last 5 years.
- Quarter analysis of 5 years shows Pharma-Bio Serv's EBIAT stood at -$4.9 million in 2021, then soared by 107.01% to $341640.0 in 2022, then crashed by 113.8% to -$47148.0 in 2023, then crashed by 226.91% to -$154130.0 in 2024, then increased by 13.53% to -$133272.0 in 2025.
- Its EBIAT stands at -$133272.0 for Q4 2025, versus -$313877.0 for Q3 2025 and -$98322.0 for Q2 2025.